Annovis Bio Inc
NYSE:ANVS
Balance Sheet
Balance Sheet Decomposition
Annovis Bio Inc
Current Assets | 10.2m |
Cash & Short-Term Investments | 5.8m |
Other Current Assets | 4.5m |
Current Liabilities | 4.3m |
Accounts Payable | 1.3m |
Accrued Liabilities | 3m |
Non-Current Liabilities | 13.7m |
Other Non-Current Liabilities | 13.7m |
Balance Sheet
Annovis Bio Inc
Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Cash & Cash Equivalents |
0
|
0
|
0
|
8
|
46
|
28
|
6
|
|
Cash Equivalents |
0
|
0
|
0
|
8
|
46
|
28
|
6
|
|
Total Receivables |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
8
|
4
|
|
Total Current Assets |
0
|
0
|
1
|
8
|
46
|
36
|
10
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
0
N/A
|
0
-86%
|
1
+2 140%
|
8
+625%
|
46
+467%
|
36
-22%
|
10
-72%
|
|
Liabilities | ||||||||
Accounts Payable |
0
|
0
|
1
|
0
|
1
|
4
|
1
|
|
Accrued Liabilities |
0
|
1
|
1
|
0
|
1
|
4
|
3
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
0
|
1
|
2
|
1
|
2
|
8
|
4
|
|
Long-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
14
|
|
Total Liabilities |
0
N/A
|
1
+16%
|
3
+360%
|
1
-78%
|
2
+160%
|
8
+410%
|
18
+133%
|
|
Equity | ||||||||
Common Stock |
7
|
7
|
7
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
7
|
8
|
9
|
14
|
29
|
54
|
110
|
|
Additional Paid In Capital |
0
|
0
|
0
|
22
|
73
|
82
|
103
|
|
Total Equity |
0
N/A
|
1
-300%
|
2
-188%
|
8
N/A
|
44
+490%
|
28
-36%
|
8
N/A
|
|
Total Liabilities & Equity |
0
N/A
|
0
-86%
|
1
+2 140%
|
8
+625%
|
46
+467%
|
36
-22%
|
10
-72%
|
|
Shares Outstanding | ||||||||
Common Shares Outstanding |
6
|
6
|
7
|
7
|
8
|
8
|
11
|